|
|
|
ZURICH (Reuters) - A new study has shown that a Novartis AG drug for treating allergic asthma can help children ages 6 to 11 years, the Swiss drugmaker said on Monday. Novartis said in a statement results of a phase III study...
ZURICH, Oct 7 (Reuters) - A Novartis AG drug, NVA237, had promising results in a mid-stage trial in patients with a progressive lung disease common among smokers, the Swiss drugmaker said on Tuesday. Once-daily treatment...
Unigene Laboratories, Inc. (OTCBB: UGNE http://www.unigene.com) has initiated a Phase I clinical study in the U.S. with its proprietary formulation of oral PTH for the treatment of osteoporosis. Twenty-four healthy...
